WallStSmart
AMRN

Amarin Corporation PLC

NASDAQ: AMRN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$14.29
+2.36% today

Updated 2026-04-29

Market cap
$292.10M
P/E ratio
P/S ratio
1.37x
EPS (TTM)
$-1.60
Dividend yield
52W range
$9 – $21
Volume
0.1M

Amarin Corporation PLC (AMRN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-22.91M$-26.28M$-26.39M$-28.11M$-33.87M$-39.44M$-122.30M$-190.34M$-72.31M$-84.75M$-71.81M$-32.84M$-94.70M$-9.37M$-21.75M$-66.53M$-179.98M$6.91M$-31.02M$6.74M
Capital expenditures$245000.00$6.22M$317000.00$126000.00$23000.00$398000.00$12.69M$14000.00$28000.00$28000.00$21000.00$12000.00$58000.00$2.48M$252000.00$2.00$1.00$24097.00$0.00$0.00
Depreciation$795000.00$386000.00$251000.00$582000.00$63000.00$76000.00$449000.00$892000.00$844000.00$812000.00$783000.00$708000.00$669000.00$859000.00$2.04M$2.86M$3.09M$2.98M$3.01M
Stock-based comp$4.63M$3.76M$10.92M$9.20M$18.32M$10.98M$8.52M$13.88M$13.61M$13.96M$18.81M$30.92M$45.81M$36.94M$26.21M$15.65M$17.70M$13.94M
Free cash flow$-23.15M$-32.50M$-26.71M$-28.24M$-33.89M$-39.84M$-135.00M$-190.35M$-72.34M$-84.78M$-71.84M$-32.85M$-94.76M$-11.84M$-22.00M$-66.53M$-179.98M$6.88M$-31.02M$6.74M
Investing cash flow$-245000.00$-4.97M$57000.00$773000.00$-23000.00$-2.05M$-14.34M$-14000.00$-28000.00$-28000.00$-21000.00$-12000.00$-58000.00$-2.48M$-376.96M$104.09M$175.18M$-25.62M$-45.98M
Financing cash flow$23.95M$12.12M$23.55M$65.67M$13.08M$126.65M$280.29M$121.62M$334000.00$72.20M$63.13M$8.23M$271.25M$409.61M$-58.91M$-5.07M$-378766.00$230891.00$-1.44M
Dividends paid$5.60M$30.26M$26.40M$2.17M$7.17M
Share repurchases
Debt repayment
Net change in cash